Btk Inhibitor

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Novartis shares surged following successful clinical trial results for remibrutinib, a new oral pill designed to treat Multiple Sclerosis.

5 sources 5 articles v 3 4h ago